Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Equity (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Return on Equity for 11 consecutive years, with 0.96% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 44.0% year-over-year to 0.96%, compared with a TTM value of 0.96% through Sep 2025, down 44.0%, and an annual FY2024 reading of 0.52%, changed N/A over the prior year.
  • Return on Equity was 0.96% for Q3 2025 at Lisata Therapeutics, down from 0.82% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.24% in Q2 2023 and bottomed at 0.96% in Q3 2025.
  • Average Return on Equity over 3 years is 0.52%, with a median of 0.46% recorded in 2024.
  • The sharpest move saw Return on Equity fell -10bps in 2024, then plummeted -44bps in 2025.
  • Year by year, Return on Equity stood at 0.37% in 2023, then tumbled by -73bps to 0.64% in 2024, then plummeted by -50bps to 0.96% in 2025.
  • Business Quant data shows Return on Equity for LSTA at 0.96% in Q3 2025, 0.82% in Q2 2025, and 0.71% in Q1 2025.